Theresa Matkovits

Theresa Matkovits currently works at GoodCap Pharmaceuticals, Inc., as Chairman from 2022 and Appili Therapeutics, Inc., as Lead Independent Director from 2018.
Dr. Matkovits also formerly worked at Aradigm Corp., as Director from 2018 to 2019, BioSurplus, Inc., as Director, Hepion Pharmaceuticals, Inc., as Chief Operating Officer from 2017 to 2018, Novartis AG, as Head-Strategic Planning & Operations from 1997 to 2010, The Medicines Co., as Vice President from 2010 to 2013, and Matinas BioPharma Holdings, Inc., as Chief Development Officer from 2018 to 2024.
Dr. Matkovits received her doctorate degree in 1994 from the University of Medicine & Dentistry of New Jersey and undergraduate degree from Alfred University.